Literature DB >> 3997206

The molecular structure of different polymorphic forms of canine C3 and C4.

P H Kay, R L Dawkins, J W Penhale.   

Abstract

The subunit composition of different electrophoretic forms of canine C3 and C4 was determined by sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of reduced immune precipitates. Canine C4 comprises alpha, beta, and gamma chains of approximate molecular weight 90 000-95 000, 72 000, and 33 000, respectively. The molecular weight of the alpha chain of the C4 1 allelic product was approximately 95 000, but 90 000 for the C4 2 and C4 4 allotypes. No differences were observed in the molecular weights of the beta or gamma chains of any canine C4 phenotype tested. Canine C3 appears to be encoded by a single locus. The subunit composition comprises an alpha and beta chain with molecular weights of approximately 106 000 and 71 000, respectively. Unlike C4, no differences in the molecular weights of the subunits were observed in different electrophoretic forms of canine C3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3997206     DOI: 10.1007/bf00430797

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  24 in total

1.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

2.  Studies of the C3 polymorphism. Rlationship between C3 phenotypes and rheumatoid arthritis.

Authors:  R Brönnestam
Journal:  Hum Hered       Date:  1973       Impact factor: 0.444

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  The purification and characterization of bovine C4, the fourth component of complement.

Authors:  N A Booth; R D Campbell; J E Fothergill
Journal:  Biochem J       Date:  1979-03-01       Impact factor: 3.857

5.  Disease associations with complotypes, supratypes and haplotypes.

Authors:  R L Dawkins; F T Christiansen; P H Kay; M Garlepp; J McCluskey; P N Hollingsworth; P J Zilko
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  Genetic polymorphism of murine C3 controlled by a single co-dominant locus on chromosome 17.

Authors:  S Natsuume-Sakai; J I Hayakawa; M Takahashi
Journal:  J Immunol       Date:  1978-08       Impact factor: 5.422

7.  The C4 beta-chain: evidence for a genetically determined polymorphism.

Authors:  G Mauff; M Steuer; M Weck; K Bender
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

8.  The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.

Authors:  D E Isenman; J R Young
Journal:  J Immunol       Date:  1984-06       Impact factor: 5.422

9.  Genetic polymorphism of the third component of human complement (C'3).

Authors:  C A Alper; R P Propp
Journal:  J Clin Invest       Date:  1968-09       Impact factor: 14.808

10.  A molecular basis for the two locus model of human complement component C4.

Authors:  M H Roos; E Mollenhauer; P Démant; C Rittner
Journal:  Nature       Date:  1982-08-26       Impact factor: 49.962

View more
  3 in total

Review 1.  A review of major histocompatibility complex-disease associations in man and dog.

Authors:  M J Day; W J Penhale
Journal:  Vet Res Commun       Date:  1987       Impact factor: 2.459

2.  Statement on the nomenclature of dog C4 allotypes.

Authors:  G Doxiadis; W Schoen; I Doxiadis; H J Deeg; G J O'Neill; H Grosse-Wilde
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

3.  The complement component C4 of mammals.

Authors:  A W Dodds; S K Law
Journal:  Biochem J       Date:  1990-01-15       Impact factor: 3.857

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.